SickKids SPIRIT-C CONSORT-C Paediatric Trials | AcademicJobs CA
SickKids' SPIRIT-C and CONSORT-C 2026 guidelines set a new benchmark for paediatric clinical trials, improving reporting for better child health outcomes.
%20Logo.png&w=256&q=75)
No reviews yet. Be the first to rate Martin!
Dr. Martin Offringa is a Senior Scientist in Child Health Evaluative Sciences and a Staff Neonatologist in the Division of Neonatology at The Hospital for Sick Children (SickKids). He holds appointments as Professor of Paediatrics and Professor and Full Graduate Faculty Member in the Institute of Health Policy, Management and Evaluation at the University of Toronto. Dr. Offringa received his MD and clinical training in paediatrics and neonatology at the Sophia Children’s Hospital in Rotterdam and the Emma Children’s Hospital in Amsterdam, followed by a PhD in clinical epidemiology from Erasmus University Rotterdam. He previously served as Director of the Dutch Cochrane Centre, founding director of the Netherlands Medicines for Children Research Network, and Program Head of Child Health Evaluative Sciences at the SickKids Research Institute for seven years. Since 2009, he has chaired the Steering Group of StaR Child Health, an international initiative to improve the design, conduct, and reporting of clinical trials in children. He is also a Scholar at the Cundill Centre for Child and Youth Depression.
Dr. Offringa leads the EnRICH Research Group and Network, which develops innovative methods to enhance the quality, ethics, and relevance of child health clinical research through initiatives such as Toronto Outcomes Research in Child Health (TORCH), PRISMA-COSMIN, CONSORT-C, SPIRIT-C, and SPOR Innovative Pediatric Clinical Trials. His professional interests include child health clinical trials, cohort studies, predictive models, clinimetrics, and decision analysis. As a neonatologist and clinical epidemiologist, his work focuses on methodological advancements that improve health outcomes for children globally, including contributions to standards for outcome measurement and trial reporting in paediatric populations.
SickKids' SPIRIT-C and CONSORT-C 2026 guidelines set a new benchmark for paediatric clinical trials, improving reporting for better child health outcomes.